Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cidara Therapeutics (CDTX) Assets Average: 2017-2025

Historic Assets Average for Cidara Therapeutics (CDTX) over the last 9 years, with Sep 2025 value amounting to $526.5 million.

  • Cidara Therapeutics' Assets Average rose 213.68% to $526.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $526.5 million, marking a year-over-year increase of 213.68%. This contributed to the annual value of $140.9 million for FY2024, which is 146.10% up from last year.
  • Latest data reveals that Cidara Therapeutics reported Assets Average of $526.5 million as of Q3 2025, which was up 45.03% from $363.0 million recorded in Q2 2025.
  • In the past 5 years, Cidara Therapeutics' Assets Average ranged from a high of $526.5 million in Q3 2025 and a low of $47.2 million during Q2 2022.
  • Moreover, its 3-year median value for Assets Average was $113.0 million (2024), whereas its average is $172.2 million.
  • Per our database at Business Quant, Cidara Therapeutics' Assets Average fell by 25.11% in 2021 and then soared by 239.49% in 2025.
  • Quarterly analysis of 5 years shows Cidara Therapeutics' Assets Average stood at $63.3 million in 2021, then dropped by 9.74% to $57.1 million in 2022, then increased by 14.86% to $65.6 million in 2023, then skyrocketed by 187.50% to $188.6 million in 2024, then spiked by 213.68% to $526.5 million in 2025.
  • Its Assets Average stands at $526.5 million for Q3 2025, versus $363.0 million for Q2 2025 and $203.3 million for Q1 2025.